Euromedica Kyanous Stavros
- Address
- Vizyis Vyzantos 1, 546 36 Thessaloniki, Greece
Euromedica Kyanous Stavros - Autoimmune Disease Research Center
Euromedica Kyanous Stavros is a specialized clinical research center with extensive expertise in autoimmune and connective tissue disorders. The center demonstrates particular strength in conducting complex Phase 2 and Phase 3 clinical trials for novel therapeutics targeting systemic autoimmune conditions, with a focus on evaluating both efficacy and long-term safety profiles of innovative treatment approaches.
- Systemic Lupus Erythematosus (SLE) research, including multiple trials investigating novel biologics and oral therapies for moderate to severe disease activity
- Systemic Sclerosis (Scleroderma) trials, evaluating both skin manifestations and pulmonary involvement in diffuse cutaneous disease
- Sjögren's Syndrome clinical investigations focused on systemic manifestations and patient-reported symptom improvement
The center's research portfolio encompasses a diverse range of therapeutic mechanisms, including B-cell targeted therapies, sphingosine-1-phosphate receptor modulators, and LPAR1 antagonists. With experience in conducting both randomized controlled trials and open-label extension studies, Euromedica Kyanous Stavros provides comprehensive evaluation of treatment efficacy, safety monitoring, and pharmacokinetic assessments for patients with complex autoimmune rheumatic diseases requiring specialized care and long-term follow-up.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 11 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Viatris Innovation GmbH1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Euromedica Kyanous Stavros
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study | Horizon Therapeutics Ireland Designated Activity Company | Phase III | Not Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dazodalibep | 3 | Unknown | 2024-06-07 | 2025-05-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.